The Enterprise Value as of December 2024 (TTM) for Adicet Bio, Inc. (ACET) is -13138580.00

According to Adicet Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -13138580.00. This represents a change of -65.52% compared to the average of -38101416.64 of the last 4 quarters.

Adicet Bio, Inc. (ACET) Historical Enterprise Value (quarterly & annually)

How has ACET Enterprise Value performed in the past?

The mean historical Enterprise Value of Adicet Bio, Inc. over the last ten years is 415.02M. The current -13138580.00 Enterprise Value has changed -416.58% with respect to the historical average. Over the past ten years (40 quarters), ACET's Enterprise Value was at its highest in in the September 2018 quarter at 2.37B. The Enterprise Value was at its lowest in in the September 2023 quarter at -102576482.10.

Adicet Bio, Inc. (ACET) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Adicet Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adicet Bio, Inc. (ACET) Average Enterprise Value

How has ACET Enterprise Value performed in the past?

The current Enterprise Value of Adicet Bio, Inc. (ACET) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adicet Bio, Inc. (ACET) Enterprise Value vs. Peers

How is ACET’s Enterprise Value compared to its peers?

Adicet Bio, Inc.’s Enterprise Value is less than Edgewise Therapeutics, Inc. (2.79B), less than Talaris Therapeutics, Inc. (503.26M), less than Cullinan Oncology, Inc. (604.04M), less than Vor Biopharma Inc. (40.41M), less than Tenaya Therapeutics, Inc. (133.85M), less than Bicycle Therapeutics plc (129.93M), less than IGM Biosciences, Inc. (379.98M), less than Monte Rosa Therapeutics, Inc. (353.71M), less than Stoke Therapeutics, Inc. (455.05M), less than Aerovate Therapeutics, Inc. (43.63M), less than Acrivon Therapeutics, Inc. Common Stock (152.40M), less than Anebulo Pharmaceuticals, Inc. (29.20M), less than Agios Pharmaceuticals, Inc. (1.78B), greater than Homology Medicines, Inc. (-103303255.00), less than Nkarta, Inc. (192.21M), less than Pliant Therapeutics, Inc. (796.04M), less than Alector, Inc. (177.19M), less than Aadi Bioscience, Inc. (43.12M), less than Keros Therapeutics, Inc. (170.95M),

Build a custom stock screener for Adicet Bio, Inc. (ACET) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adicet Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adicet Bio, Inc. (ACET) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adicet Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.